Amgen stock after-hours: EUR 369.03, prior close EUR 354.53
Published on 10/07/2026 at 20:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Amgen stock was at EUR 369.03 after-hours at 8:36 p.m. CEST on October 7, 2026. The quote was EUR 14.50 above the prior close at Lang & Schwarz, an increase of 4.09 percent.
Trading on October 7
The previous Lang & Schwarz closing price was EUR 354.53. The quote showed a bid of EUR 369.00 and an ask of EUR 369.05. The recorded quote time was 8:36:21 p.m. CEST, placing the price in the after-hours period for investors in Germany. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Amgen stock.
Clinical program update
In a release dated September 22, 2026, Amgen said its Phase 3 OASIZ 301 study of dazodalibep in adults with moderate-to-severe systemic Sjögren's disease met its primary endpoint at Week 48. The company said the improvement in systemic disease activity was statistically significant and clinically meaningful, with improvements observed as early as Week 4 and sustained through Week 48. Amgen said the study included approximately 621 participants and that it plans to present detailed data at an upcoming medical meeting. The Phase 3 OASIZ 303 study is expected to complete in the fourth quarter of 2026.
